cd117 car-t cells
Cell therapyexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2018 (NCT03473457)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetImmunity, passive
cd117
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07144020 | Early Phase 1 (Phase 1) | Sep 5, 2025 | Yake Biotechnology Ltd., Zhejiang University |
| NCT03473457 | N/A | Apr 1, 2018 | Southern Medical University, Sun Yat-Sen University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Southern Medical University | Academic/Hospital | 1 | 1 | 1 | 2018 |
| Sun Yat-Sen University | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Yake Biotechnology Ltd. | Government | 1 | 0 | 1 | 2025 |
| Zhejiang University | Academic/Hospital | 1 | 1 | 1 | 2025 |
4 organizations
Page 1 / 1